On Monday, Voyager Therapeutics Inc (NASDAQ: VYGR) was 4.58% up from the session before settling in for the closing price of $3.93. A 52-week range for VYGR has been $2.64 – $7.44.
A company in the Healthcare sector has jumped its sales by 1.48% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -86.19%. With a float of $45.80 million, this company’s outstanding shares have now reached $55.48 million.
Voyager Therapeutics Inc (VYGR) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Voyager Therapeutics Inc stocks. The insider ownership of Voyager Therapeutics Inc is 17.63%, while institutional ownership is 55.86%. The most recent insider transaction that took place on Oct 03 ’25, was worth 36,643. In this transaction Chief Financial Officer of this company sold 7,666 shares at a rate of $4.78, taking the stock ownership to the 123,834 shares. Before that another transaction happened on Oct 03 ’25, when Company’s Officer proposed sale 5,843 for $4.78, making the entire transaction worth $27,937.
Voyager Therapeutics Inc (VYGR) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.59 earnings per share (EPS) during the time that was less than consensus figure (set at -0.35) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -86.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.48% during the next five years compared to 1.48% growth over the previous five years of trading.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
You can see what Voyager Therapeutics Inc (VYGR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.17, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.56 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.44 million. That was inferior than the volume of 0.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.93%.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 47.06%, which indicates a significant increase from 32.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.26 in the past 14 days, which was lower than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.54, while its 200-day Moving Average is $3.80. However, in the short run, Voyager Therapeutics Inc’s stock first resistance to watch stands at $4.24. Second resistance stands at $4.36. The third major resistance level sits at $4.56. If the price goes on to break the first support level at $3.92, it is likely to go to the next support level at $3.72. Assuming the price breaks the second support level, the third support level stands at $3.60.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
There are 55,600K outstanding shares of the company, which has a market capitalization of 228.52 million. As of now, sales total 80,000 K while income totals -65,000 K. Its latest quarter income was 5,200 K while its last quarter net income were -33,380 K.
